This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Results of Treatment in Seventeen Cases with a New Sulfonamide (Gantrisin®)

PAUL S. RHOADS, M.D.; FLOYD A. SVEC, M.D.; JOSEPH H. ROHR, M.D.

Arch Intern Med. 1950;85(2):259-264.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN A PREVIOUS communication,¹ our clinical experience with gantrisin,^® a new sulfonamide with the formula 3,4-dimethy1-5-sulfanilamido-isoxazole, was reported. Its use as the sole bacteriostatic agent in 53 patients with various infections and in combination with antibiotics in 38 others was reported, the entire series including practically all the conditions for which sulfonamides are currently used. The results on the whole were satisfactory. In the series of 91 patients reactions of some type occurred in 9, anorexia in 1, nausea in 5, vomiting in 2, headache in 1, a generalized eruption in 1 and crystalluria in 2. No hematuria or renal blocking was noted. More than 100 patients have been treated since that report with approximately the same results.

Since many of the conditions for which sulfonamides are commonly prescribed are self limiting, we felt that a separate and somewhat more detailed report of our results in bacterial meningitis—a . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Medicine, Northwestern University Medical School.

Footnotes
Gantrisin was formerly known as NU 445.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?